Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion type Assertion NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_head.
- NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion description "[The EphA2 tyrosine kinase receptor is frequently overexpressed in ovarian cancer and this feature is predictive of poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_provenance.
- NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion evidence source_evidence_literature NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_provenance.
- NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion SIO_000772 16969087 NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_provenance.
- NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion wasDerivedFrom befree-2016 NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_provenance.
- NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_assertion wasGeneratedBy ECO_0000203 NP569021.RAHBvPayOCEVW9S8v1x2x_KZGdaFX77htAcvhYM2ZpphU130_provenance.